Hoelting K, Madlmayr A, Hoeger B, Lewitz D, Weng M, Haider T
bioRxiv. 2024; .
PMID: 39677770
PMC: 11643021.
DOI: 10.1101/2024.12.04.626765.
Gujarathi R, Franses J, Pillai A, Liao C
Front Oncol. 2024; 14:1432423.
PMID: 39267840
PMC: 11390354.
DOI: 10.3389/fonc.2024.1432423.
Danielpour D
Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675493
PMC: 11054419.
DOI: 10.3390/ph17040533.
Guo Y, Xu T, Chai Y, Chen F
Int J Mol Sci. 2023; 24(12).
PMID: 37373414
PMC: 10299206.
DOI: 10.3390/ijms241210263.
Sun L, Su Y, Jiao A, Wang X, Zhang B
Signal Transduct Target Ther. 2023; 8(1):235.
PMID: 37332039
PMC: 10277291.
DOI: 10.1038/s41392-023-01471-y.
Intricacies of TGF-β signaling in Treg and Th17 cell biology.
Wang J, Zhao X, Wan Y
Cell Mol Immunol. 2023; 20(9):1002-1022.
PMID: 37217798
PMC: 10468540.
DOI: 10.1038/s41423-023-01036-7.
Identification of Novel Loci Shared by Juvenile Idiopathic Arthritis Subtypes Through Integrative Genetic Analysis.
Li J, Li Y, Glessner J, Yang J, March M, Kao C
Arthritis Rheumatol. 2022; 74(8):1420-1429.
PMID: 35347896
PMC: 9542075.
DOI: 10.1002/art.42129.
Signaling Pathways Tuning Innate Lymphoid Cell Response to Hepatocellular Carcinoma.
Bourayou E, Golub R
Front Immunol. 2022; 13:846923.
PMID: 35281021
PMC: 8904901.
DOI: 10.3389/fimmu.2022.846923.
Overcoming TGFβ-mediated immune evasion in cancer.
Tauriello D, Sancho E, Batlle E
Nat Rev Cancer. 2021; 22(1):25-44.
PMID: 34671117
DOI: 10.1038/s41568-021-00413-6.
Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment.
Liu Z, Liu J, Staiculescu D, Chen J
Ther Adv Med Oncol. 2021; 13:17588359211018026.
PMID: 34104226
PMC: 8150670.
DOI: 10.1177/17588359211018026.
ADAM9 enhances Th17 cell differentiation and autoimmunity by activating TGF-β1.
Umeda M, Yoshida N, Hisada R, Burbano C, Orite S, Kono M
Proc Natl Acad Sci U S A. 2021; 118(18).
PMID: 33911034
PMC: 8106302.
DOI: 10.1073/pnas.2023230118.
The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation.
Wu B, Zhang S, Guo Z, Bi Y, Zhou M, Li P
Immunity. 2021; 54(2):308-323.e6.
PMID: 33421362
PMC: 7878438.
DOI: 10.1016/j.immuni.2020.12.010.
The induction and function of the anti-inflammatory fate of T17 cells.
Xu H, Agalioti T, Zhao J, Steglich B, Wahib R, Amezcua Vesely M
Nat Commun. 2020; 11(1):3334.
PMID: 32620760
PMC: 7335205.
DOI: 10.1038/s41467-020-17097-5.
The role of transforming growth factor-beta in immune suppression and chronic inflammation of squamous cell carcinomas.
Strait A, Wang X
Mol Carcinog. 2020; 59(7):745-753.
PMID: 32301180
PMC: 7282943.
DOI: 10.1002/mc.23196.
Transforming Growth Factor-β Signaling in Immunity and Cancer.
Batlle E, Massague J
Immunity. 2019; 50(4):924-940.
PMID: 30995507
PMC: 7507121.
DOI: 10.1016/j.immuni.2019.03.024.
Phosphatase PP2A is essential for T17 differentiation.
Xu Q, Jin X, Zheng M, Rohila D, Fu G, Wen Z
Proc Natl Acad Sci U S A. 2018; 116(3):982-987.
PMID: 30593560
PMC: 6338861.
DOI: 10.1073/pnas.1807484116.
Protective Regulatory T Cell Immune Response Induced by Intranasal Immunization With the Live-Attenuated Pneumococcal Vaccine SPY1 the Transforming Growth Factor-β1-Smad2/3 Pathway.
Liao H, Peng X, Gan L, Feng J, Gao Y, Yang S
Front Immunol. 2018; 9:1754.
PMID: 30116243
PMC: 6082925.
DOI: 10.3389/fimmu.2018.01754.
Trim33 mediates the proinflammatory function of Th17 cells.
Tanaka S, Jiang Y, Martinez G, Tanaka K, Yan X, Kurosaki T
J Exp Med. 2018; 215(7):1853-1868.
PMID: 29930104
PMC: 6028517.
DOI: 10.1084/jem.20170779.
Effector T Helper Cell Subsets in Inflammatory Bowel Diseases.
Imam T, Park S, Kaplan M, Olson M
Front Immunol. 2018; 9:1212.
PMID: 29910812
PMC: 5992276.
DOI: 10.3389/fimmu.2018.01212.
The role of transforming growth factor β in T helper 17 differentiation.
Zhang S
Immunology. 2018; 155(1):24-35.
PMID: 29682722
PMC: 6099164.
DOI: 10.1111/imm.12938.